| ||||||||||||||
|
|
|||||||||||||

From the Departments of *Anaesthesia and
Surgery, Ullevaal University Hospital; and University of Oslo, Faculty Division, Ullevaal University Hospital, Oslo, Norway.
Address correspondence and reprint requests to Johan Raeder, Department of Anaesthesia, Ullevaal University Hospital, N-0407 Oslo, Norway. Address e-mail to johan.rader{at}medisin.uio.no.
Abstract
BACKGROUND: Glucocorticoids provide analgesia. In this study, we evaluated the effects of adding dexamethasone to a multimodal postoperative analgesic regimen, including a long-acting nonsteroidal antiinflammatory drug.
METHODS: One-hundred patients admitted for ambulatory breast cancer surgery were studied. They received paracetamol 2 g and rofecoxib 50 mg orally 1 h before start of general anesthesia with propofol and remifentanil. The patients were then randomized to receive, in a double-blind manner, either dexamethasone 16 mg IV or placebo. Both groups received fentanyl 1 µg/kg IV and 20–40 mL bupivacaine 2.5 mg/mL wound infiltration before the end of surgery.
RESULTS: There was no difference in pain scores or rescue medication between the groups during the first 4 h after surgery. After discharge, the median pain score during coughing or shoulder movement was 3 on a 0–10 scale in patients receiving placebo, and 1 in the patients receiving dexamethasone, which did not reach statistical significance (P = 0.06). From 24 to 72 h, the median pain with coughing or shoulder movement in patients receiving placebo was 2, and 1 in patients receiving dexamethasone, which did reach statistical significance (P < 0.05). Forty percent of patients receiving dexamethasone were pain free from 4 to 24 h, compared with 24% of patients receiving placebo, a difference that did not reach statistical significance (P = 0.09). Similarly, 46% of patients receiving dexamethasone were pain free from 24 to 72 h, compared with 28% of patients receiving placebo (P = 0.06). More patients had slept poorly on the first night in the dexamethasone group than in the control group, 68% vs 44%, (P < 0.05).
CONCLUSIONS: Dexamethasone 16 mg provides prolonged postoperative analgesia from 24 to 72 h after surgery when added to a multimodal regimen including nonsteroidal antiinflammatory drug (rofecoxib).
This article has been cited by other articles:
![]() |
O. Mathiesen, L. S. Jacobsen, H. E. Holm, S. Randall, L. Adamiec-Malmstroem, B. K. Graungaard, P. E. Holst, K. L. Hilsted, and J. B. Dahl Pregabalin and dexamethasone for postoperative pain control: a randomized controlled study in hip arthroplasty Br. J. Anaesth., October 1, 2008; 101(4): 535 - 541. [Abstract] [Full Text] [PDF] |
||||
|